Company News

Procter & Gamble Granted Cell Research License from Geron

Author Image

By: TOM BRANNA

Editor

Biopharmaceutical company Geron Corp., Menlo Park, CA, has granted a non-exclusive license to Procter & Gamble Company for Geron’s human telomerase reverse transcriptase technology in cell research applications. Financial terms of the agreement were not disclosed.The technology will allow Procter & Gamble to conduct repeated or long-term studies on the biology and function of cells using hTERT technology, which proliferate indefinitely while maintaining normal physical and biolog...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters